An unexpected cause of massive hemolysis in percutaneous left ventricular assist device

Cardiovascular Revascularization Medicine

Volumn 14, Issue 1, 2013, Pages 66-67

  Tanawuttiwat, Tanyanan ^a   Chaparro, Sandra V ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Hemolysis; Impella; Percutaneous left ventricular assist device

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; FEMALE; HEART TRANSPLANTATION; HEMOLYSIS; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; SHOCK, CARDIOGENIC; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84872561113     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2012.10.011     Document Type: Article

References (3)

1. Dixon S.R., Henriques J.P., Mauri L., Sjauw K., Civitello A., Kar B., et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2009, 2(2):91-96.
2. Seyfarth M., Sibbing D., Bauer I., Frohlich G., Bott-Flugel L., Byrne R., et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008 Nov 4, 52(19):1584-1588.
3. Sibbald M., Dzavík V. Severe hemolysis associated with use of the impella LP 2.5 mechanical assist device. Catheter Cardiovasc Interv 2012, (Epub).